Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts

Biomarkers

Volumn 18, Issue 3, 2013, Pages 196-203

  Oelsner, E C ^a   Pottinger, T D ^a   Burkart, K M ^a   Allison, M ^b   Buxbaum, S G ^c   Hansel, N N ^d   Kumar, R ^e   Larkin, E K ^f   Lange, L A ^g   Loehr, L R ^h   London, S J ⁱ   O'Connor, G T ^j   Papanicolaou, G ^k   Petrini, M F ^l   Rabinowitz, D ^m   Raghavan, S ^a   Redline, S ⁿ   Thyagarajan, B ^o   Tracy, R P ^p   Wilk, J B ⁿ   White, W B ^q   Rich, S S ^r   Barr, R G ^a,s   more..

^a Columbia University ^*  (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c JACKSON STATE UNIVERSITY   (United States)

^d Department of Medicine ^*  (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h IL   (United States)

ⁱ NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^j BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^l UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^m Och Spine at New York Presbyterian Hospitals   (United States)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^p UNIVERSITY OF VERMONT   (United States)

^q TOUGALOO COLLEGE   (United States)

^r UNIVERSITY OF VIRGINIA   (United States)

^s NONE   (United States)

more..

Author keywords

Genetic polymorphisms; Growth factors cytokines inflammatory mediators; Respiratory disease

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; COHORT STUDIES; E-SELECTIN; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUNG; MALE; MIDDLE AGED; P-SELECTIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 84876578788     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.762805     Document Type: Article

References (45)

1. Bielinski SJ, Pankow JS, Li N, et al. (2008). ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 201: 339-44.
2. Carratu P, Scoditti C, Maniscalco M, et al. (2008). Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension. BMC Pulm Med 8: 20.
3. Celik G, Karabiyikoglu G. (1998). Local and peripheral plasma endothelin-1 in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Respiration 65: 289-94. (Pubitemid 28404632)
4. Cella G, Sbarai A, Mazzaro G, et al. (2001). Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clin Appl Thromb Hemost 7: 205-8. (Pubitemid 32574181)
5. Chalmers GW, Macleod KJ, Sriram S, et al. (1999). Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease. Eur Respir J 13: 1288-92. (Pubitemid 29357144)
6. Dahl M, Vestbo J, Zacho J, et al. (2011). C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax 66: 197-204.
7. Decramer M, Janssens W, Miravitlles M. (2012). Chronic obstructive pulmonary disease. Lancet 379: 1341-51.
8. Di Stefano A, Maestrelli P, Roggeri A, et al. (1994). Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 149: 803-10. (Pubitemid 24082245)
9. Dinh-Xuan AT, Higenbottam TW, Clelland CA, et al. (1991). Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 324: 1539-47.
10. Distasi MR, Ley K. (2009). Opening the flood-gates: how neutrophilendothelial interactions regulate permeability. Trends Immunol 30: 547-56.
11. Ebrahim S, Davey Smith G. (2008). Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet 123: 15-33
12. Elliott P, Chambers JC, Zhang W, et al. (2009). Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302: 37-48.
13. Ferroni P, Basili S, Martini F, et al. (2000). Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med 48: 21-7. (Pubitemid 30485618)
14. Fijnheer R, Frijns CJ, Korteweg J, et al. (1997). The origin of P-selectin as a circulating plasma protein. Thromb Haemost 77: 1081-5. (Pubitemid 27311973)
15. Glymour MM, Tchetgen EJ, Robins JM. (2012). Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. Am J Epidemiol 175: 332-9.
16. Hankinson JL, Kawut SM, Shahar Eet al. (2010). Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest 137: 138-45.
17. Hankinson JL, Odencrantz JR, Fedan KB. (1999). Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159: 179-87. (Pubitemid 29036522)
18. Helset E, Lindal S, Olsen R, et al. (1996). Endothelin-1 causes sequential trapping of platelets and neutrophils in pulmonary microcirculation in rats. Am J Physiol 271: L538-46.
19. Hogg JC, Chu F, Utokaparch S, et al. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-53. (Pubitemid 38787999)
20. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. (2009). Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301: 2331-9.
21. Lawlor DA, Harbord RM, Sterne JA, et al. (2008). Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27: 1133-63. (Pubitemid 351395448)
22. Linsel-Nitschke P, Gotz A, Erdmann J, et al. (2008). Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease-a Mendelian randomisation study. PLoS One 3: e2986.
23. Musunuru K, Lettre G, Young T, et al. (2010). Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 3: 267-75.
24. Noguera A, Busquets X, Sauleda J, et al. (1998). Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 1664-8.
25. Petrache I, Natarajan V, Zhen L, et al. (2005). Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11: 491-8. (Pubitemid 40685971)
26. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. (1992). Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 187: 584-9.
27. Price AL, Patterson NJ, Plenge RM, et al. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-9. (Pubitemid 44141658)
28. Purcell S, Neale B, Todd-Brown Ket al. (2010). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-75. [http://pngu.mgh.harvard.edu/purcell/plink/]. (Pubitemid 47330214)
29. Qi L, Cornelis MC, Kraft P, et al. (2010). Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 19: 1856-62.
30. Redington AE, Springall DR, Ghatei MA, et al. (1995). Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Respir Crit Care Med 151: 1034-9.
31. Riise GC, Larsson S, Lofdahl CG, Andersson BA. (1994). Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur Respir J 7: 1673-7. (Pubitemid 24294255)
32. Roland M, Bhowmik A, Sapsford RJ, et al. (2001). Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 56: 30-5. (Pubitemid 32041716)
33. Rothman KJ. (1990). No adjustments are needed for multiple comparisons. Epidemiology 1: 43-6. (Pubitemid 20255621)
34. Rusznak C, Mills PR, Devalia JL, et al. (2000). Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 23: 530-6.
35. Spiropoulos K, Trakada G, Nikolaou E, et al. (2003). Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma. Respir Med 97: 983-9. (Pubitemid 36944131)
36. Thyagarajan B, Smith LJ, Barr RG, et al. (2009). Association of circulating adhesion molecules with lung function. The CARDIA study. Chest 135: 1481-7.
37. Trakada G, Tsourapis S, Marangos M, Spiropoulos K. (2000). Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir Med 94: 992-6.
38. van Durme YM, Lahousse L, Verhamme KM, et al. (2011). Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease. Respiration 82: 530-8.
39. Vittori E, Marini M, Fasoli A, et al. (1992). Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis 146: 1320-5.
40. Voelkel NF, Cool CD. (2003). Pulmonary vascular involvement in chronic obstructive pulmonary disease. Eur Respir J Suppl 46: 28s-32s. (Pubitemid 37351734)
41. Voight BF, Peloso GM, Orho-Melander M, et al. (2012). Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 380: 572-80.
42. Walter RE, Wilk JB, Larson MG, et al. (2008). Systemic inflammation and COPD: the Framingham Heart Study. Chest 133: 19-25.
43. Yamakami T, Taguchi O, Gabazza EC, et al. (1997). Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise. Eur Respir J 10: 2055-60. (Pubitemid 27406441)
44. Yanagisawa M, Kurihara H, Kimura S, et al. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-15. (Pubitemid 18090241)
45. Zeger SL, Liang KY. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-30.